Thirteenth Starr Cancer Consortium Grant Competition

  • Dietary regulation of cancer immunity
    Principal Investigator:

    • Semir Beyaz, PhD – Cold Spring Harbor Laboratory

    Co-Principal Investigators:

    • Christopher Mason, PhD – Weill Cornell Medicine
    • Kivanc Birsoy, PhD – The Rockefeller University
    Abstract
  • Metabolic coupling of hypoxia to intratumoral heterogeneity

    Principal Investigator:

    • Andrew Intlekofer, MD, PhD – Memorial Sloan Kettering Cancer Center

    Co-Principal Investigators:

    • Tuomas Tammela, MD, PhD – Memorial Sloan Kettering Cancer Center
    • Michael Hemann, PhD – The Broad Institute of MIT and Harvard
    Abstract
  • Chemical disruption of kinase-to-chromatin signaling in chemotherapy-refractory leukemia

    Principal Investigator:

    • Christopher R. Vakoc, MD, PhD – Cold Spring Harbor Laboratory

    Co-Principal Investigators:

    • Nathanael Gray, PhD – The Broad Institute of MIT and Harvard
    • Alex Kentsis, MD, PhD – Memorial Sloan Kettering Cancer Center
    Abstract 
  • Visualizing targeted killing of cancer cells by therapeutic T-cells at the nanoscale

    Principal Investigator:

    • Gregory Alushin, PhD – The Rockefeller University

    Co-Principal Investigators:

    • Joel Meyerson, PhD – Weill Cornell Medicine
    • Morgan Huse, PhD – Memorial Sloan Kettering Cancer Center
    • Michel Sadelain, MD, PhD – Memorial Sloan Kettering Cancer Center
    Abstract 
  • The role of telomerase in healing broken chromosomes in cancer

    Principal Investigator:

    • John Maciejowski, PhD – Memorial Sloan Kettering Cancer Center

    Co-Principal Investigators:

    • Marcin Imielinski, MD, PhD – Weill Cornell Medicine
    • Titia de Lange, PhD – The Rockefeller University
    Abstract 
  • Detection of impending infections in immunocompromised cancer patients

    Principal Investigator:

    • Justin Cross, PhD – Memorial Sloan Kettering Cancer Center

    Co-Principal Investigators:

    • Sean Brady, PhD – The Rockefeller University
    • Jonathan Peled, MD – PhD – Memorial Sloan Kettering Cancer Center
    • Michael Satlin, MD – Weill Cornell Medicine
    • Ying Taur, MD – Memorial Sloan Kettering Cancer Center
    • Marcel van den Brink, MD, PhD – Memorial Sloan Kettering Cancer Center
    • Lars Westblade, PhD – Weill Cornell Medicine
    Abstract  
  • Modifiers of BRCA2 tumor suppressor loss of function

    Principal Investigator:

    • Maria Jasin, PhD – Memorial Sloan Kettering Cancer Center

    Co-Principal Investigators:

    • Tarun Kapoor, PhD – The Rockefeller University
    • Willliam Holloman, PhD – Weill Cornell Medicine
    Abstract 
  • EGFR inhibition in lung cancer: resistance, sensitization, and combination therapy

    Principal Investigator:

    • Matthew Meyerson, MD, PhD – The Broad Institute of MIT and Harvard

    Co-Principal Investigators:

    • Helena Yu, MD – Memorial Sloan Kettering Cancer Center
    • Marc Ladanyi, MD – Memorial Sloan Kettering Cancer Center
    Abstract  
  • Microbiome-derived hydrogen sulfide as a trigger for CIMP colorectal cancer

    Principal Investigator:

    • Steven S. Gross, PhD – Weill Cornell Medicine

    Co-Principal Investigator:

    • Andrew Intlekofer, MD, PhD – Memorial Sloan Kettering Cancer Center
    Abstract